Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 85c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $66.48 -1.86%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($1.38), $0.85 worse than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Accenture and Anthropic partner on AI safety evaluation team
- Teva shares Phase 3 data on once-monthly schizophrenia injection
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
